Is TECH a good stock to buy?
We came across a bullish thesis on Bio-Techne Corporation on r/ValueInvesting by Dynaheir-be
In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation’s share was trading at $52.65 as of June 8th. TECH’s trailing and forward P/E were 74.27 and 25.51 respectively according to Yahoo Finance.
Pressmaster/ Bio-Techne Corporation (TECH) is positioned as a high-quality life sciences “picks and shovels” supplier operating at the core of global drug discovery and biomedical research. The company manufactures critical reagents, antibodies, proteins, and instruments used by pharmaceutical R&D teams, biotech firms, and academic laboratories worldwide, functioning as an essential upstream enabler rather than a drug developer. 15 AI Stocks That Are Quietly Making Investors Rich Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential Its business model is defined by structurally elevated 65–70% gross margins, a strong base of recurring consumables revenue, and deeply entrenched switching costs driven by experimental reproducibility requirements, where validated reagents are reordered under identical catalog numbers for years. This creates persistent demand visibility and citation-driven lock-in across published scientific literature, reinforcing long-duration customer retention.